2nd Annual Biobanking Summit
02-03

March 2017

Germany

Berlin

Hotel Riu Plaza Berlin

Martin-Luther-Straße 1, 10777

About Summit

Our 2nd Annual Biobanking Summit will feature innovative discussions on relevant and critical issues on how to improve biobanking practices. Through a series of interactive presentations, panel discussions and round-tables, this Summit will focus on modern biobanking insights, challenges and innovations; long-term sustainability; advanced big data tools; future trends; and the latest technological developments and regulatory updates.

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Managers and Scientists specialising in:

  • Biologics Sample Management
  • Drug Discovery
  • Scientific Investigation
  • Biobanking
  • Biosample Management
  • Pathology
  • Bioinnovation
  • Population Based Biobanks
  • Quality control
  • System Development
  • Business Development
  • Laboratory Compliance
  • Research
  • Cell Banks
  • Biorepository
  • Pharmacogenomics
  • Genomics
  • Molecular Technologies
  • Disease Based Biobanks
  • R&D
  • Data Privacy & Protection

From Industries Including:

  • Pharma
  • Biotechnology
  • Molecular genetics
  • Biomedical
  • Research institutions within industry
  • CMO
  • Biopharma
  • Drug discovery
  • Biotechnologies
  • Hospitality and Healthcare
  • CRO
Key Practical Learning Points of the Summit

How to design a modern biobanking
Ethical, privacy and legal challenges in managing bio samples
How big data is impacting biobanking
Smart biobanking: the focus on long term sample management and quality solutions
Clinical trials: risk-mitigation strategies
Biobanking as a significant tool for biomarker discovery, validation and efficiency
Innovative research, technologies and therapeutic solutions in oncology
The influence of biobanking on the development of precision medicine
The integrated genomics approach
Novelties and new strategies of biobanking’s role in targeted and rare disorders research
Speakers
Erik Steinfelder

Biobank Commercial Leader

Thermo Fisher Scientific

Dr. Dejun Tang

Global Head of Biostatistics & Clinical Submission Management

Sandoz, a Novartis Division

Prof. Dr. Elke Smits

President

ESBB Biobanking Society

Dr. Brian Paul Lockhart

Director of Biotechnology Biomarker Research Division

Servier

Dr. Maria Hernandez-Fuentes

Head of Translational Biology for Immunology

UCB

Dr. Liddy Chen

Senior Director Biostatistics

PAREXEL International

Dr. Nicola Orlandi

Head Data Privacy Pharma

Novartis

Dr. Barbara Baert

Head of Flex Laboratory

Janssen: Pharmaceutical Companies of Johnson & Johnson

Andy Nelson

Associate Director Informatics & Cloud Operations

Illumina

Annual

Events

Sponsors and Partners

Sponsor

Sponsor

Sponsor

Media partner

Media partner

Media partner